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Abstract
Background: Unstable settings present challenges for the effective provision of antiretroviral treatment (ART). In this
paper, we summarize the experience and results of providing ART and implementing contingency plans during acute
instability in the Central African Republic (CAR) and Yemen.
Case presentation: In CAR, MSF has provided HIV care in three conflict-affected rural regions; these were put on hold
throughout the acute phase of violence. “Run-away bags” containing 3 or 4 months of ART were distributed to patients
at MSF facilities. Among 1820 HIV patients enrolled into care, 1440 (79%) initiated ART. By December 2016, 782 (54%)
patients were still under ART, 354 (25%) have been lost to follow up and 182 (13%) had died. In 2013, when violence
disrupted services, 683 patients were receiving ART. Between September–December 2013, 594 (87%) patients received
runaway bags and by February 2014, 313 (53%) of these patients returned to the clinic.
In Yemen, when violence erupted, patients received a health card that included a helpline to call in case of drug shortages
in admission to emergency stocks; this was not possible in CAR due to lack of a functioning telephone network.
One thousand six hundred fifty-five PLWHA have been enrolled in care and 1470 (89%) initiated ART; 1056 (72%)
are still followed on ART, 126 (9%) were lost to follow up, and 288 (20%) died. In January 2011 clashes began and
by April 2011 MSF medical activities were interrupted. Of the 363 patients receiving ART, 363 (100%) received
emergency bags to cover 9 months and by February 2012, 354 (98%) patients returned to care. In March 2015 a
new wave of conflict affected Yemen, forcing HIV activities to revert to contingency planning.
Conclusions: This experience provides further evidence that provision of HIV treatment and emergency drug stocks
can be successfully provided to most patients in both conflict-affected settings.
Keywords: HIV, Conflict, Contingency plan, Emergency response
Background
Globally, an estimated 36.7 million people were living
with HIV at the end of 2017 and 21 million of them
were on antiretroviral therapy (ART). While this reflects
substantial progress in scaling up access to care and
treatment, still around half of the patients in need of
ART have yet to be diagnosed or enrolled into care [1].
Among the many challenges faced in reaching more
people with HIV, populations affected by humanitarian
emergencies are particularly underserved. In 2014 it was
estimated that 1.6 million people living with HIV were
affected by humanitarian emergencies, of them 81% were
in sub-Saharan Africa and almost two thirds (1 million)
did not have access to ART [2].
Conflict-affected settings present a particular challenge
for the effective provision of HIV care for a multitude of
reasons, including the impact of the conflict on the local
and national health systems, population movement, and
the enduring view among providers of care that the
provision of ART in these settings is not feasible [3–5].
Furthermore, concerns have been raised that providing
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ART could cause harm by putting patients at risk of drug
resistance if ART was interrupted. Limited epidemio-
logical data and programme experiences and lack of polit-
ical will to prioritize the needs of displaced or conflict
affected populations have all contributed to neglect HIV
services in these settings [6]. Restricted movement can
further deter clinic visits during periods of conflict, limit-
ing access to care and treatment [7].
Data on the feasibility and impact of providing ART in
conflict and emergency settings are limited. During the
post-election conflict in Kenya during 2007–2008, treat-
ment interruption was 71% higher compared to the
period prior to the conflict, with Médecins sans Fron-
tières (MSF) reporting around 30% of patients missing
pills [8, 9]. A report from 22 MSF programs where ART
was initiated in conflict or post-conflict settings, 64% of
patients remained on ART with a rate of loss of follow
up of 11% [10, 11].
MSF works in conflict-affected settings responding to
the acute needs of these populations during the collapse
of health services. In some of these settings HIV preva-
lence is high, leading to considerable HIV-related health
needs. In many of these settings without access to HIV
services, HIV-associated mortality is very high among
hospitalized patients [12, 13].
In this paper we share our experience of providing
ART in two conflict affected settings in Africa and the
Middle-east. The aim of this paper is summarize differ-
ent operational approaches that have been successfully
implemented in different contexts experiencing periods





CAR has endured decades of instability, trapped in a
cycle of constant and interminable conflict since the late
1990s. In some parts of the country as much as half the
population are affected by conflict, with many displaced
from their homes. The negative health effects of these con-
flicts are considerable, in addition to impacting schooling
for children, agricultural production, access to functioning
markets and the degradation of essential infrastructure
including roads.
HIV prevalence in CAR is among the highest in Central
and Western Africa, estimated at 4.9–10% amongst adults
according to different UN sources [14, 15]. Before a surge
in violence in 2013, around 15,000 people living with HIV
(PLWH) were on ART. The biggest concern for the HIV
programme was interruption of ART due to stock rup-
tures and loss of HIV patients on treatment due to inse-
curity and displacement. Both events may have affected
thousands of PLWH and could have led to increased
mortality and the development of drug resistance. Possibly
reflecting these risks, rates of treatment failure in CAR are
high and estimated at 30% in adults and 50% in children
[16, 17]. More than a fifth (3000) of patients experiencing
treatment failure had developed drug resistance. The abil-
ity of the health system to handle ART failure is insuffi-
cient, with few qualified health workers, no second-line
ART available, extremely limited access to virological
monitoring, and frequent and long-term nationwide
shortages of medical supplies [18]. Adding to these con-
cerns, the breakdown of law and order led to widespread
violations of human rights including sexual and gender
based violence and rape [19].
MSF Spain has been present in CAR since 1996 in the
north and central part of the country – Kabo, Batangafo
and Ndele towns – 3 rural areas chronically affected by
conflict (Fig. 1). In 2008 HIV care was integrated into
the existing health services.
Program design and implementation
HIV services began by addressing patients presenting at
the inpatient department (IPD), malnourished children,
patients with tuberculosis (TB) or any sign suggesting
HIV infection, and prevention of mother-to-child trans-
mission (PMTCT) at antenatal clinics (ANC). Later in
2010, a voluntary counselling and testing service (VCT)
and health promotion activities were added.
HIV protocols and ART eligibility criteria were in line
with the National AIDS Program (NAP) until 2012 when,
with the agreement from Ministry of Health (MOH), MSF
introduced tenofovir (TDF) based fixed-dose combina-
tions as first line therapy to replace existing stavudine
(d4T) based regimens following 2010 WHO recommen-
dations [20]. Option B+ for PMTCT was implemented in
2014. In November 2016 the NAP adopted the WHO
recommendations to start ART to all individuals as soon
as possible following an HIV diagnosis; however imple-
mentation of such recommendations is still very slow.
Fig. 1 MSF Project Kabo, CAR
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Implementation of these activities was mostly organised
by a HIV experienced international doctor providing
training to national and international staff, implementing
protocols, setting up data collection systems, and monitor-
ing activities. HIV testing and counselling (HTC) was per-
formed by trained community healthcare workers (CHW)
using rapid test kits, while clinical consultations were run
by nurses supported by a doctor in complicated cases.
HIV and TB consultations were integrated into the OPD.
Tracing of defaulters was done by CHWs and included
tracing of patients under TB treatment, although these ac-
tivities where not always done due to limitations on access
linked with insecurity.
Clinical monitoring was done every 1–3 months de-
pending on adherence and security conditions. No regular
access to CD4 or viral load was available. Point of care
devices to measure creatinine and haemoglobin were
available to support ARV regimen choices. There was no
NAP electronic database and MOH ART registers were
used to report a list of indicators entered into the Health
Information System (HIS) used by MSF Spain. Tracing of
patients lost to care was not always possible due to secur-
ity concerns, so the outcomes of many patients lost to care
are not known.
Overall, 1820 patients were diagnosed with HIV and
enrolled into care between 2008 and 2016. 1440 (79%)
patients initiated ART, including 90 (8%) children. Median
age was 31.7 years old, 1231 (67%) patients were classified
as WHO stage 3 or 4 at admission and 77% of the patients
started on ART were women. 538 (37%) of the enrolled
patients underwent CD4 cell count testing; 333 (61.8%)
had CD4 cell count < 200 cell/mm3, 217 (12%) CD4 cell
count 200–500 cells/mm3 and 50 (2.7%) patients had a
CD4 cell count > 500 cells/mm3. By September 2013,
when the context became increasingly unstable, 683 (60%)
patients remained under ART and active follow-up.
Contingency planning
A contingency plan to ensure continuation of ART in case
of insecurity was implemented in 2010 covering different
security scenarios, from low levels of insecurity with
short-term break in services up to full evacuation of most
of the staff and distribution of “run-away” packs contain-
ing 2 extra months of ARVs plus a 1 week tail protection
with AZT/3TC in cases of high insecurity [11]. Patients
were informed about what to do in case of violence during
routine counselling sessions and national staff were
trained on how to prepare in case of evacuation.
In September 2013 the security situation deteriorated,
with several armed attacks displacing the population in the
MSF supported region with many people crossing the
border to Chad. During the initial phase of the plan,
patients came to the MSF-supported health clinics to
receive extra ARVs (2 months’ supply) and were provided
information about what to do in case treatment interrup-
tion occurred given the unpredictable situation. There were
several patients living in more remote areas who could not
reach the clinic and MSF staff could not move, leaving a
number of patients’ without access to drugs (Fig 2).
In January 2014 the international MSF team had to be
evacuated and all HIV services where put on hold except
for PMTCT that continued with the national staff that
remained in the Hospital. HIV activities where reini-
tiated in July 2014 when situation became more stable
and the MSF team could return.
The contingency plan was rapidly implemented to
ensure continuation of treatment in case of population
movement or MSF evacuation. Run away bags were
distributed to 594 (87%) patients during the peak of vio-
lence between September and December 2013. By Feb-
ruary 2014, 313 (52%) of those patients had returned for
consultation. By December 2016, since the beginning of
the programme 782 (54%) patients started on ART were
still under active follow up, 354 (25%) patients had been
lost to follow up and 182 (13%) had died. Only 26 pa-
tients (0.1%) had received a second line regimen. These
outcomes, while not optimal, are in line with outcomes
reported over similar time periods in stable settings: a
recent report from 57 cohorts from 22 countries found
that 52.1% of patients were retained on ART, 41.8% were
lost to follow-up and 6.0% had died 5 years after ART
initiation [21].
During 2016 viral load monitoring was implemented
by sending dried blood spot samples to an external
laboratory in South Africa; during this time 390 samples
were sent and 212 (54%) results were available. 139
(66%) patients were virologicaly suppressed and 71
(33%) had a viral load higher than 1000 copies/ml. Those
with a high VL were provided enhanced adherence
support and switched to second line if needed.
Fig. 2 MSF response during acute conflict in CAR 2013
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Yemen
Context
Yemen is frequently affected by intra-state conflicts.
The HIV epidemic is described as a mature, low-level
epidemic with prevalence estimated at 0.2% in the gen-
eral population; however Yemen has a concentrated
HIV epidemic among men who have sex with men
(MSM) with an estimated prevalence of 5.9%. It is esti-
mated that at the end of 2013 there were 35,000 people
living with HIV in Yemen [22].
MSF has been present in Yemen since 2007 in the Awhar
region covering Abyan and Shabwa Governorates with
medical programs responding to violence. In February 2009
an assessment of access to HIV services found high levels
of stigma and discrimination; patients were being rejected
from the hospitals because of their positive status, surgeries
had been denied and HIV-positive pregnant women had to
attend private clinics to deliver. In response, MSF decided
to start HIV services supporting the National AIDS
Programme in the capital of Sana’a with the main objective
of increasing access to HIV care and reducing stigma and
discrimination (Fig. 3).
Program design and implementation
The main HIV activities were to provide support to the
National AIDS Programme in Sana’s city at the ART
clinic in Al-Ghomouri Hospital. MSF support included
training of national staff, covering ARV stock ruptures
and a major focus on health promotion and advocacy
efforts towards reduction of stigma and discrimination
aimed at the community, patients and hospital staff.
HIV testing was available at the clinic and patients
could self-present or be referred. Community outreach
activities including health promotion were carried out to
increase HIV awareness and testing. HIV protocols and
ART eligibility criteria were in line with the National
AIDS Program (NAP) and in 2010 a TDF based fixed-
dose combination as first line was implemented to re-
place existing stavudine-based regimens following WHO
recommendations [20].
Since the war in 2015, a policy of “Treat all” was imple-
mented by the NAP to facilitate treatment initiation of
patient’s diagnosed HIV positive and avoid loss to follow
up of patients prior to ART.
HIV activities were initially implemented by inter-
national staff that performed mentoring activities with
national doctors at the government HIV clinic in Sana’a.
Clinical trainings were provided to medical and non-
medical staff of the hospital as a way to increase aware-
ness about HIV and decrease stigma. Since 2011 due to
the unstable situation, the MSF HIV program has been
entirely run by national staff.
Patients were reviewed monthly for the first year after
ART initiation, then every 3 months depending on adher-
ence, per national guidelines. CD4 was done at baseline
and every 6 months on treatment; targeted viral load was
used to detect treatment failure but was not accessible for
routine monitoring. Point of care devices to measure cre-
atinine and haemoglobin were used to support ARV regi-
men choice. In 2010 MOH implemented Tier.net as an
M&E tool for the entire country, starting with Sana’a as
pilot project [23].
Since the beginning of the project in 2010, 1655 pa-
tients were diagnosed HIV positive, 1470 (89%) were
started on ART, 126 (9%) were lost to follow up, 288
(20%) died and 1056 (72%) are still under care as of De-
cember 2016. Thirty seven patients (4%) are receiving a
second line regimen. When the crisis broke out in 2011,
there were 363 patients under ART.
Contingency planning
In February 2011, government loyalists and opposition
tribesmen clashed during protests in Yemen, especially
in the capital Sana’a, against the regime of President Ali
Abdullah Saleh. The situation subsequently devolved
into open fighting between military forces loyal to the
government, defecting military forces, and tribal militia
in the capital Sana’a in May 2011.
Unlike in CAR, there was no contingency plan defined
at the beginning of the program and the team was
forced to develop a plan to ensure ART continuation. All
HIV services were interrupted, including HIV testing
and ART initiation for new patients.
All patients received a “health card” describing the
ARV regimen they were receiving, what to do in case of
inability to reach the health facility, and an emergency
phone number to call in case they ran out of drugs. The
nurse in charge of the pharmacy removed the patient’s
registers and ARVs from the clinic to his house and
started calling all patients to deliver run-away bags and
managed the emergency phone line. Patients called the
phone number if they had any questions prior to the
next drug refill and arranged with the MSF team drug
distribution in different areas of the city. An extra ART
Fig. 3 MSF HIV Project Sanaa, Yemen
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site was allocated out of the area most affected by the
clashes where patients could go to pick up drugs. This
system lasted for 7 months and patients could call the
MSF nurse if they were running out of drugs or needed
psychosocial support. A contingency plan was developed
building on these lessons to prepare for future episodes of
instability and shared with the National AIDS Programme.
Between April and November 2011, 363 (100%) patients
received run-away bags with an extra 2 months of drugs
and by February 2012, 354 (98%) patients had returned for
their follow up consultation. No patient reported having
had to interrupt their treatment.
After activities resumed in 2014 the war started again
in April 2015, at which point the contingency plan was
again enacted, with the support from peer patients and
associations of PLWH, whose work helped ensure the
continuation of treatment for patients. This time patients
were given 3–4 months of drugs to try and minimise the
risk of treatment disruptions.
Conclusions
Our experience adds to the growing evidence that
provision of HIV services in conflict-affected settings is
feasible with simplified models and strategies and should
be included in the comprehensive medical response in
conflict-affected populations. This includes contingency
plans to respond in case of emergencies implemented
from the beginning of the intervention and linked with
proper counselling and patient information. Simplified
protocols are consistent with a public health approach
to ART delivery [24] and have been successfully applied
in other African countries where basic laboratory com-
modities and human resources are limited, without com-
promising quality.
This experience demonstrates the value of implement-
ing different strategies according to the challenges: in
places with high HIV prevalence and low resources
available, a step-wise approach initially targeting the
sickest patients (e.g. those admitted to IPDs, malnutri-
tion centres and TB wards) could be the preferred
option until capacity is built to extend care to all HIV
patients. In places where a lower number of HIV pa-
tients are expected, strategies targeting all HIV infected
populations in all medical departments could be feasible.
In our program both strategies were tailored to the
setting. CAR with a higher HIV prevalence started tar-
geting the sicker patients while in Yemen a full package
of HIV activities was implemented from the beginning of
the intervention. In both settings the inclusion of a focal
person for the implementation of HIV activities (e.g.
training of national staff, setting up of basic activities
and supervision of the HIV program) was an added
value and it allowed a more rapid start of activities
compared to other projects where there have not been
any extra person to start HIV care.
Outcomes described in this case study are similar
to other non-conflict affected African countries [25],
although rates of loss to follow up were higher in
CAR particularly after the 2013 peak of violence pos-
sibly related to the high mobility of the population.
Retention in care and viral suppression in CAR was
similar to other reports in African countries without
security issues. It is important to note that few
patients are receiving second line regimens in our
programs mainly due to the limited availability of
virological monitoring to detect treatment failure.
In Yemen the outcomes of the contingency plan
were better than those observed in CAR despite not
having a plan beforehand. This difference could be re-
lated to the fact that Sana’a is an urban area where
patients can still look for a safer place and it has
more reliable access to telephone and communication
networks, whereas the rural areas of CAR without ac-
cess to phone networks and not many options to seek
safer places, makes this setting more challenging to
ensure access of and to patients.
These results have in part been achieved by helping
to empower and educate patients since the beginning
of the intervention and encouraging them to be
responsible for their own treatment. Still today, very
few actors and donors are willing to support HIV
services in countries chronically affected by violence
and HIV packages are rarely included in the initial
response to emergencies, despite a consensus state-
ment made in 2006 by WHO, UNHCR, UNAIDS,
MSF and UNICEF that ARV delivery should be
included as part of comprehensive HIV services in
emergency settings [26].
Rates of loss to follow up are much higher in CAR
despite improved counselling approaches and adequate
defaulter tracing systems; this might be due to the fre-
quent episodes of violence in the area and the continu-
ous internal displacement.
Preferably, contingency plans should be in place from
the beginning of the programme, prior to the onset of the
emergency. Nevertheless, our experience in Yemen shows
that even in the absence of a prior contingency plan, sim-
ple actions can be taken rapidly to ensure continuity of
care. Pharmacy management should also be included with
the contingency plan to ensure the availability of enough
drugs for the times of acute instability when drugs for 4–
6 months are given to patients. This could jeopardize fur-
ther supply if not planned beforehand.
The recommendation to treat all HIV positive patients
regardless of clinical or immunological status provides
an opportunity to improve access to ART in conflict set-
tings where very often there is no access to CD4 or viral
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load monitoring and ART coverage lies far behind other
countries in the Sub-Saharan Africa region. Differenti-
ated models of care including simplification of protocols,
task shifting, patient and community involvement [27],
and contingency planning are additional elements that
support ART delivery in such settings.
There is a need to ensure access to HIV services,
including ART in conflict settings which have some
of the lowest rates of treatment coverage world-wide.
Places like South Sudan, or most of the Western and
Central African countries (WCA) are among the re-
gions with ART coverage below 50% [28]; improved
access to HIV services are urgently needed in these
settings if we want to reach the UNAIDS 90–90-90
targets. Funding and support to implement these ac-
tivities is a major concern when other “competing
priorities” are prioritized and main donors maintain a
focus of funding for specific fields of interest. Donor
support could be crucial to close the gaps when talk-
ing about ART services in acute emergencies [29].
Our case studies demonstrate the importance and
feasibility of providing HIV care in conflict affected
populations in both low and high prevalence HIV set-
tings. Simplified protocols and strategies tailored to
the context should be thought about when providing
access to health care in these settings.
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